GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation
Journal of Pharmaceutical Analysis · 2024-05 · 14 (5) · 100917
DOI: 10.1016/j.jpha.2023.12.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2024-05. Verfasst von Jiani Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, 410011, China. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Many medical conditions, including hypertension, diabetes, obesity, sleep apnea, and heart failure (HF), increase the risk for AF. Cardiomyocytes have unique metabolic characteristics to maintain adenosine triphosphate production. Significant changes occur in myocardial metabolism in AF. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been used to control blood glucose fluctuations and weight in the treatment of type 2 diabetes mellitus (T2DM) and obesity. GLP-1RAs have also been shown to reduce oxidative stress, inflammation, autonomic nervous system modulation, and mitochondrial function. This article reviews the changes in metabolic characteristics in cardiomyocytes in AF. Although the clinical trial outcomes are unsatisfactory, the findings demonstrate that GLP-1 RAs can improve myocardial metabolism in the presence of various risk factors, lowering the incidence of AF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, 410011, China.
- Xiangya School of Medicine, Central South University, Changsha, 410008, China.
- Center for Precision Medicine and Division of Cardiovascular Medicine, Department of Medicine, School of Medicine, University of Missouri, Columbia, MO, 65211, USA.
Zitieren
APA
Zhong, J., Chen, H., Liu, Q., Zhou, S., Liu, Z., & Xiao, Y. (2024). GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation. Journal of Pharmaceutical Analysis, 14(5), 100917. https://doi.org/10.1016/j.jpha.2023.12.007
Vancouver
Zhong J, Chen H, Liu Q, Zhou S, Liu Z, Xiao Y. GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation. Journal of Pharmaceutical Analysis. 2024;14(5):100917. doi:10.1016/j.jpha.2023.12.007
BibTeX
@article{Zhong2024,
author = {Zhong, Jiani and Chen, Hang and Liu, Qiming and Zhou, Shenghua and Liu, Zhenguo and Xiao, Yichao},
title = {GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation},
journal = {Journal of Pharmaceutical Analysis},
year = {2024},
volume = {14},
number = {5},
pages = {100917},
doi = {10.1016/j.jpha.2023.12.007}
}
EUVIMED